Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Passage BIO, Inc. COMMON STOCK (PASG).
- Disclosed ownership: 7.8%.
- Date of event: 17 Jul 2025.
ORBIMED ADVISORS LLC - 17 Jul 2025 SCHEDULE 13D/A Report for Passage BIO, Inc. COMMON STOCK (PASG)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Security
- Passage BIO, Inc. COMMON STOCK
- Symbol
- PASG
- Shares outstanding
- 3,118,645 shares
- Disclosed Ownership
- 243,878 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 21 Jul 2025, 17:28:32 UTC
- Date of event
- 17 Jul 2025
- Previous filing
- 09 Jul 2025
- Next filing
- 24 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 7.8% ownership in Passage BIO, Inc. COMMON STOCK (PASG) on 17 Jul 2025."
What Changed
- Previous schedule filing date: 09 Jul 2025.
- Current filing was accepted on 21 Jul 2025, 17:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.8% | 243,878 | 0 | 243,878 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| ORBIMED CAPITAL GP VII LLC | 7.8% | 243,878 | 0 | 243,878 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001760648 |